Further validation and signaling pathway analyses revealed that ox-LDL binds to the bladder cancer cell membrane receptor CD36 and affects the intracellular JAK2-STAT3 signaling pathway, thereby regulating tumor cell stemness-related genes and promoting bladder cancer cell proliferation. The gene discussed is JAK2; the disease is urinary bladder cancer.